Testing a new stapler to prevent pancreatic leaks after surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new type of stapler (AEON) used during surgery to remove the left part of the pancreas. The goal is to see if it helps reduce the risk of a leak from the pancreas after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are scheduled to have surgery to remove the left part of your pancreas (distal pancreatectomy).
- You have not had any previous surgeries on your pancreas.
- Your surgery will not remove any other organs (except possibly the spleen or left adrenal gland).
- You are not taking part in another clinical trial that could interfere with this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
This trial looks at factors that can predict a serious complication called a pancreatic fistula (a leak from the pancreas) after a Whipple procedure. The goal is to help doctors better understand and manage this risk.
This trial looks at how often a small pancreatic stent (a plastic tube placed during an ERCP procedure) dislodges or causes problems. It may help patients who are getting a stent to prevent pancreatitis.
This trial tests if a medicine called lanreotide, given before surgery, can prevent a common complication (pancreatic leak) after removing part of the pancreas. It is for people with pancreatic cancer or a growth that could become cancer who are scheduled for a specific type of pancreas surgery.
This trial is testing whether adding a special connection (Braun anastomosis) between two parts of the small intestine during pancreas surgery can reduce delayed stomach emptying, a common problem after the procedure.
This study looks at how tiny particles in blood (“exosomes”) carry signals between cells in people having pancreatic surgery. The goal is to understand these signals in different pancreatic conditions and treatment situations, which may help future care.
Hear when a new Pancreas; Fistula trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.